5 amino-1mq 5-Amino-1MQ (5-Amino-1-Methylquinolinium Chloride) – 98%+ Purity – 5g 5A-1-Molecule (5 Amino 1mq) 50mg

GLP-1 agonist FDA-approved once-weekly 0.252.4 mg Dual GIP/GLP-1 agonist FDA-approved once-weekly 2.515 mg Triple agonist (GLP-1/GIP/glucagon) Phase 3 once-weekly 112 mg Dual GLP-1/glucagon agonist Phase 3 once-weekly trial-reported dosing Amylin analog Phase 3 once-weekly 1.24.5 mg HGH fragment preclinical/community daily 300600 mcg NNMT inhibitor preclinical oral 50-150 mg optional SubQ vial math Oral monoamine reuptake inhibitor trial dosing 0.25-0.5 mg daily Tissue Repair & Recovery Peptides Healing-focused compounds studied for tendon, ligament, muscle, and gut tissue repair

AOD-9604 at its best produced around 2-3 kg over 12 weeks in a controlled setting and struggled to replicate that in a longer, more rigorous trial

This selectivity is particularly important for individuals seeking pure fat reduction rather than body recomposition, those who do not want muscle hypertrophy for aesthetic or functional reasons, athletes in weight-class sports who need fat loss without muscle gain, individuals with contraindications to growth-promoting interventions, and those concerned about cell proliferation effects

These effects potentially spur muscle gain, weight gain, and overall strength